Fig. 4.

Fluorescence imaging study of cell uptake of doxorubicin by MDCK-MDR cells (P-gp positive). Cells were treated with a 50 nM free doxorubicin, b 50 nM doxorubicin and 50 nM quercetin, and c 50 nM DoxQ